Please use this identifier to cite or link to this item: https://ri.ufs.br/jspui/handle/riufs/25158
Document Type: Artigo
Title: Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 diabetic patients: a systematic review and meta-analysis
Authors: Aguiar, Patricia Melo
Brito, Giselle de Carvalho
Lima, Tácio de Mendonça
Santos, Ana Patrícia Alves Lima
Lyra Júnior, Divaldo Pereira
Issue Date: 2016
Resumo : Objective: To assess the effect of pharmacist interventions on glycemic control in type 2 diabetic patients and to examine factors that could explain the variation across studies. Methods: A comprehensive literature search was performed in PubMed, Scopus, and LILACS databases for randomized controlled trials (RCTs) published up to July 2015. The search strategy included the use of MeSH terms or text words related to pharmacist interventions, type 2 diabetes, and randomized controlled trials. RCTs published in English, Portuguese, or Spanish that evaluated the effect of pharmacist intervention on glycemic control in type 2 diabetic outpatients were included. Two independent authors executed study selection, data extraction, and risk of bias assessment. Mean differences in glycosylated hemoglobin (HbA1c) were estimated using random-effect models, and heterogeneity was evaluated by subgroup and meta-regression analyses. Results: The literature search yielded 963 records of potential interest, of which 30 were included in the systematic review and 22 in the meta-analysis. Most of these RCTs were conducted in the United States in patients in outpatient clinics using face-to-face contact only. All RCTs performed patient education, and most executed the medication review. The appraised sample showed uncertain or high risk of bias in most of the items evaluated, resulting in low-quality studies. In comparison with usual care, pharmacist interventions were associated with significant reductions in HbA1c levels (-8.5% [95% CI: -1.06, -0.65]; P < 0.0001; I 2 = 67.3%). Subgroup analysis indicated differences of heterogeneity by country, baseline HbA1c levels, setting, intervention frequency, and random allocation. Age and HbA1c levels partly explained the variability across studies by meta-regression. Conclusions: Our findings confirmed that pharmacist interventions improve glycemic control in patients with type 2 diabetes compared with usual care and suggest that younger patients or with higher baseline HbA1c levels may be the main beneficiaries of pharmacist care.
Keywords: Glycemic control
Pharmacists
Randomized controlled trials
Type 2 diabetes
ISSN: 1932-6203
Is part of: PloS One
Language: eng
Publisher / Institution : Public Library of Science
Citation: AGUIAR, P. M. et al. Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 diabetic patients: a systematic review and meta-analysis. PloS one, San Francisco, v. 11, n. 3, 2016. Disponível em: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0150999. Acesso em: 19 maio 2026.
License: Creative Commons Atribuição 4.0 Internacional (CC BY 4.0)
Identifier: https://doi.org/10.1371/journal.pone.0150999
URI: https://ri.ufs.br/jspui/handle/riufs/25158
Appears in Collections:DFA - Artigos de periódicos

Files in This Item:
File Description SizeFormat 
SourcesHeterogeneityRandomizedControlledTrials.pdf892,27 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.